Printer Friendly Version View printer-friendly version
<< Back
Sleep Number Announces Record Fourth-Quarter and Full-Year 2017 Results
  • Fourth-quarter net sales grew 16% to $363 million, with full-year net sales up 10% to a record $1.44 billion
  • Reported 2017 EPS growth of 41% to $1.55, including fourth-quarter EPS of $0.39
  • Generated record full-year operating free cash flow of $113 million
  • Increased its revolving credit facility from $153 million to $300 million
  • Provides 2018 earnings outlook of $1.70 to $2.00 per diluted share, an increase of 10% to 29% versus 2017

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 15, 2018-- Sleep Number Corporation (NASDAQ: SNBR) today reported record results for the year ended December 30, 2017, including fourth-quarter results which exceeded expectations.

“Our consumer innovation strategy delivered market share growth and accelerated returns in 2017,” said Shelly Ibach, president and chief executive officer of Sleep Number. “Consumers are embracing the sleep and wellness benefits of our revolutionary Sleep Number 360™ smart bed. We look forward to having our full line of smart beds in market by mid-year 2018 and continuing to advance our supply chain initiatives for greater efficiency.”

Fourth-quarter Statement of Operations Review

  • Net sales increased 16% to $363 million, including a 12% comparable sales increase and 4 percentage points (ppt) of growth from stores opened in the last twelve months
  • Operating income increased 31% to $20 million, or 5.5% of net sales, a 60 basis-point rate improvement versus the prior year’s fourth quarter
  • Earnings per diluted share increased 56% to $0.39, including 6 cents of tax benefits primarily due to application of the Tax Cuts and Jobs Act enacted in December 2017

Full-year Statement of Operations Review

  • Net sales increased 10% to $1.44 billion in 2017, including a 4% comparable sales gain and 7 ppt of growth from new stores
  • Operating income increased 20% to $92 million, or 6.4% of net sales, a 60 basis-point rate improvement versus the prior year
  • Earnings per diluted share increased 41% to $1.55, compared to $1.10 in 2016, including 6 cents of tax benefits primarily due to application of the Tax Cuts and Jobs Act enacted in December 2017

Cash Flows and Balance Sheet Review

  • Operating cash flows increased 14% to a record $173 million, compared with $152 million in 2016
  • Invested $60 million in capital expenditures, compared with $58 million in 2016, with $487 million invested in the business over the past six years in the form of capital expenditures and acquisitions
  • Increased share repurchases 20% to $150 million in 2017, bringing total returns to shareholders to $488 million over the past six years; $465 million remains available under our share repurchase authorization
  • Return on invested capital (ROIC) was 14.3% for the year, well above our weighted average cost of capital
  • On February 14, 2018 we amended our revolving credit facility to increase our net aggregate availability from $153 million to $300 million. We maintained the accordion feature which allows us to increase the amount of the credit facility from $300 million to $450 million, subject to lenders' approval. The credit agreement matures in February 2023

Financial Outlook
The company expects to generate full-year 2018 earnings per diluted share of between $1.70 and $2.00, a 10% to 29% increase versus full-year 2017 earnings per diluted share of $1.55. The outlook assumes mid-to- high single digit sales growth for 2018. The 2018 outlook assumes an estimated effective income tax rate of 25%, based on the new tax legislation enacted in December 2017. The company anticipates 2018 capital expenditures to be approximately $50 million. Our outlook contemplates a slow growth economy.

Conference Call Information
Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EST (4 p.m. CST; 2 p.m. PST) today. To listen to the call, please dial 800-593-9959 (international participants dial 517-308-9340) and reference the passcode “Sleep.” To access the webcast, please visit the investor relations area of the Sleep Number website at http://www.sleepnumber.com/eng/aboutus/InvestorRelations.cfm. The webcast replay will remain available for approximately 60 days.

About Sleep Number Corporation
As the leader in sleep innovation, Sleep Number Corporation delivers the best quality sleep through effortless, adjustable comfort and biometric sleep tracking. Sleep Number is a visionary in health and wellness, proving the connection between quality sleep and wellbeing. With its SleepIQ® technology platform, powering one of the most comprehensive databases of biometric consumer sleep data in the world, Sleep Number is fundamentally changing the way we monitor and manage health. To experience better quality sleep, visit one of the over 550 Sleep Number® stores located in all 50 states or SleepNumber.com. For additional information, visit our newsroom and investor relations site.

Forward-looking Statements
Statements used in this news release relating to future plans, events, financial results or performance are forward-looking statements subject to certain risks and uncertainties including, among others, such factors as current and future general and industry economic trends and consumer confidence; the effectiveness of our marketing messages; the efficiency of our advertising and promotional efforts; our ability to execute our company-controlled distribution strategy; our ability to achieve and maintain acceptable levels of product and service quality, and acceptable product return and warranty claims rates; our ability to continue to improve and expand our product line; consumer acceptance of our products, product quality, innovation and brand image; industry competition, the emergence of additional competitive products, and the adequacy of our intellectual property rights to protect our products and brand from competitive or infringing activities; availability of attractive and cost-effective consumer credit options; pending and unforeseen litigation and the potential for adverse publicity associated with litigation; our “just-in-time” manufacturing processes with minimal levels of inventory, which may leave us vulnerable to shortages in supply; our dependence on significant suppliers and our ability to maintain relationships with key suppliers, including several sole-source suppliers; the vulnerability of key suppliers to recessionary pressures, labor negotiations, liquidity concerns or other factors; rising commodity costs and other inflationary pressures; risks inherent in global sourcing activities; risks of disruption in the operation of either of our two primary manufacturing facilities; increasing government regulations, which have added or may add cost pressures and process changes to ensure compliance; the adequacy of our management information systems to meet the evolving needs of our business and to protect sensitive data from potential cyber threats; the costs, distractions and potential disruptions to our business related to upgrading our management information systems; our ability to attract, retain and motivate qualified management, executive and other key employees, including qualified retail sales professionals and managers; and uncertainties arising from global events, such as terrorist attacks, political unrest or a pandemic outbreak, or the threat of such events. Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.

 
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
               
 
Three Months Ended
December 30, % of December 31, % of
2017

 Net Sales 

2016

 Net Sales 

 
Net sales $ 363,279 100.0 % $ 313,445 100.0 %
Cost of sales   142,475   39.2 %   115,963   37.0 %
Gross profit   220,804   60.8 %   197,482   63.0 %
 
Operating expenses:
Sales and marketing 161,793 44.5 % 152,368 48.6 %
General and administrative 32,036 8.8 % 23,472 7.5 %
Research and development   6,856   1.9 %   6,330   2.0 %
Total operating expenses   200,685   55.2 %   182,170   58.1 %
Operating income 20,119 5.5 % 15,312 4.9 %
Other expense, net   (209 ) (0.1 %)   (136 ) 0.0 %
Income before income taxes 19,910 5.5 % 15,176 4.8 %
Income tax expense   4,119   1.1 %   3,889   1.2 %
Net income $ 15,791   4.3 % $ 11,287   3.6 %
 
Net income per share – basic $ 0.40   $ 0.25  
 
Net income per share – diluted $ 0.39   $ 0.25  
 

Reconciliation of weighted-average shares outstanding:

Basic weighted-average shares outstanding 39,627 44,501
Dilutive effect of stock-based awards   1,037     869  
Diluted weighted-average shares outstanding   40,664     45,370  
 
 
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
               
Twelve Months Ended
December 30, % of December 31, % of
2017

 Net Sales 

2016

 Net Sales 

 
Net sales $ 1,444,497 100.0 % $ 1,311,291 100.0 %
Cost of sales   547,150   37.9 %   501,131   38.2 %
Gross profit   897,347   62.1 %   810,160   61.8 %
 
Operating expenses:
Sales and marketing 650,357 45.0 % 595,845 45.4 %
General and administrative 127,269 8.8 % 109,674 8.4 %
Research and development   27,806   1.9 %   27,991   2.1 %
Total operating expenses   805,432   55.8 %   733,510   55.9 %
Operating income 91,915 6.4 % 76,650 5.8 %
Other expense, net   (877 ) (0.1 %)   (717 ) (0.1 %)
Income before income taxes 91,038 6.3 % 75,933 5.8 %
Income tax expense   25,961   1.8 %   24,516   1.9 %
Net income $ 65,077   4.5 % $ 51,417   3.9 %
 
Net income per share – basic $ 1.58   $ 1.11  
 
Net income per share – diluted $ 1.55   $ 1.10  
 

Reconciliation of weighted-average shares outstanding:

Basic weighted-average shares outstanding 41,212 46,154
Dilutive effect of stock-based awards   873     748  
Diluted weighted-average shares outstanding   42,085     46,902  
 
 
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Balance Sheets
(unaudited – in thousands, except per share amounts)
subject to reclassification
       
December 30, December 31,
2017 2016
Assets
Current assets:
Cash and cash equivalents $ 3,651 $ 11,609

Accounts receivable, net of allowance for doubtful accounts of $714 and $884, respectively

19,312 19,705
Inventories 84,298 75,026
Prepaid expenses 17,565 8,705
Other current assets   27,665   23,282
Total current assets 152,491 138,327
 
Non-current assets:
Property and equipment, net 208,646 208,367
Goodwill and intangible assets, net 77,588 80,817
Deferred income taxes 2,625 4,667
Other non-current assets   30,484   24,988
Total assets $ 471,834 $ 457,166
 
Liabilities and Shareholders’ Equity
Current liabilities:
Borrowings under revolving credit facility $ 24,500 $ -
Accounts payable 129,194 105,375
Customer prepayments 27,767 26,207
Accrued sales returns 19,270 15,222
Compensation and benefits 34,602 19,455
Taxes and withholding 24,234 23,430
Other current liabilities   46,822   35,628
Total current liabilities 306,389 225,317
 
Non-current liabilities:
Other non-current liabilities   76,289   71,529
Total liabilities 382,678 296,846
 
Shareholders’ equity:

Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding

- -

Common stock, $0.01 par value; 142,500 shares authorized, 38,813 and 43,569 shares issued and outstanding, respectively

388 436
Additional paid-in capital - -
Retained earnings   88,768   159,884
Total shareholders’ equity   89,156   160,320
Total liabilities and shareholders’ equity $ 471,834 $ 457,166
 
 
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(unaudited - in thousands)
subject to reclassification
       
Twelve Months Ended
December 30, December 31,
2017 2016
 
Cash flows from operating activities:
Net income $ 65,077 $ 51,417

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization 61,291 57,172
Stock-based compensation 15,763 11,961
Net loss on disposals and impairments of assets 249 27
Excess tax benefits from stock-based compensation - (517 )
Deferred income taxes 2,042 (1,640 )
Changes in operating assets and liabilities:
Accounts receivable 393 9,297
Inventories (9,272 ) 11,574
Income taxes 1,697 25,119
Prepaid expenses and other assets (12,405 ) (2,195 )
Accounts payable 21,779 (4,965 )
Customer prepayments 1,560 (25,266 )
Accrued compensation and benefits 15,398 2,808
Other taxes and withholding (893 ) 2,723
Other accruals and liabilities   9,928     14,130  
Net cash provided by operating activities   172,607     151,645  
 
Cash flows from investing activities:
Purchases of property and equipment (59,829 ) (57,852 )
Proceeds from sales of property and equipment 36 92
Investments in marketable debt securities - (5,968 )
Proceeds from marketable debt securities - 21,053
Decrease in restricted cash   3,150     -  
Net cash used in investing activities   (56,643 )   (42,675 )
 
Cash flows from financing activities:
Net increase in short-term borrowings 28,094 5,932
Repurchases of common stock (155,245 ) (126,693 )
Proceeds from issuance of common stock 3,241 2,298
Excess tax benefits from stock-based compensation - 517
Debt issuance costs   (12 )   (409 )
Net cash used in financing activities   (123,922 )   (118,355 )
 
Net decrease in cash and cash equivalents (7,958 ) (9,385 )
Cash and cash equivalents, at beginning of period   11,609     20,994  
Cash and cash equivalents, at end of period $ 3,651   $ 11,609  
 
 
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Supplemental Financial Information
(unaudited)
               
Three Months Ended Twelve Months Ended
December 30, December 31, December 30, December 31,
2017 2016 2017 2016
 
Percent of sales:
Retail 91.7 % 91.0 % 91.7 % 91.0 %
Online and phone 7.7 % 7.9 % 7.0 % 6.7 %
Wholesale/other   0.6 %   1.1 %   1.3 %   2.3 %
Total   100.0 %   100.0 %   100.0 %   100.0 %
 
Sales change rates:
Retail comparable-store sales 12 % 30 % 3 % 0 %
Online and phone   13 %   91 %   16 %   25 %
Company-Controlled comparable sales change 12 % 34 % 4 % 1 %
Net opened/closed stores   4 %   12 %   7 %   7 %
Total Company-Controlled Channel 16 % 46 % 11 % 8 %
Wholesale/other   (35 %)   29 %   (38 %)   5 %
Total   16 %   46 %   10 %   8 %
 
Stores open:
Beginning of period 553 527 540 488
Opened 6 15 36 72
Closed   (3 )   (2 )   (20 )   (20 )
End of period   556     540     556     540  
 
Other metrics:
Average sales per store ($ in 000's) 1 $ 2,420 $ 2,364
Average sales per square foot 1 $ 920 $ 937
Stores > $1 million net sales 1 98 % 98 %
Stores > $2 million net sales 1 61 % 61 %
Average revenue per mattress unit 2 $ 4,421 $ 4,093 $ 4,283 $ 4,046
 

1 Trailing twelve months for stores open at least one year.

2 Represents Company-Controlled Channel total net sales divided by Company-Controlled Channel mattress units.
 
 
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
(in thousands)
             
We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:
 
Three Months Ended Trailing-Twelve Months Ended
December 30, December 31, December 30, December 31,
2017 2016 2017 2016
 
Net income $ 15,791 $ 11,287 $ 65,077 $ 51,417
Income tax expense 4,119 3,889 25,961 24,516
Interest expense 227 186 975 811
Depreciation and amortization 15,237 14,564 61,077 56,910
Stock-based compensation 3,954 2,689 15,763 11,961
Asset impairments 20 43 244 74
       
Adjusted EBITDA $ 39,348   $ 32,658   $ 169,097 $ 145,689
 
 
 
 
Free Cash Flow
(in thousands)
 
Three Months Ended Trailing-Twelve Months Ended
December 30, December 31, December 30, December 31,
2017 2016 2017 2016
 
Net cash (used in) provided by operating activities $ (3,447 ) $ 6,384 $ 172,607 $ 151,645
Subtract: Purchases of property and equipment   22,216     19,083     59,829   57,852
Free cash flow $ (25,663 ) $ (12,699 ) $ 112,778 $ 93,793
 
 

Note - Our Adjusted EBITDA calculation and our "free cash flow" data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

 
GAAP - generally accepted accounting principles in the U.S.
 
 

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Calculation of Return on Invested Capital (ROIC)

(in thousands)

 

ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our invested capital. Management believes ROIC is also a useful metric for investors and financial analysts. We compute ROIC as outlined below. Our definition and calculation of ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile net operating profit after taxes (NOPAT) and total invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

       
Trailing-Twelve Months Ended

December 30,
2017

December 31,
2016

Net operating profit after taxes (NOPAT)

Operating income $ 91,915 $ 76,650
Add: Rent expense 1 74,019 67,416
Add: Interest income 97 94
Less: Depreciation on capitalized operating leases 2 (18,865 ) (17,185 )
Less: Income taxes 3   (48,970 )   (41,933 )
NOPAT $ 98,196 $ 85,042
 

Average invested capital

Total equity $ 89,156 $ 160,320
Less: Cash greater than target 4 - -
Add: Long-term debt 5 - -
Add: Capitalized operating lease obligations 6   592,152     539,328  
Total invested capital at end of period $ 681,308 $ 699,648
 
Average invested capital 7 $ 686,436 $ 699,576
 
Return on invested capital (ROIC) 8   14.3 %   12.2 %
 

1 Rent expense is added back to operating income to show the impact of owning versus leasing the related assets.

 

2 Depreciation is based on the average of the last five fiscal quarters' ending capitalized operating lease obligations (see note 6) for the respective reporting periods with an assumed thirty-year useful life. This is subtracted from operating income to illustrate the impact of owning versus leasing the related assets.

 

3 Reflects annual effective income tax rates, before discrete adjustments, of 33.3% and 33.0% for 2017 and 2016, respectively.

 

4 Cash greater than target is defined as cash, cash equivalents and marketable debt securities less customer prepayments in excess of $100 million.

 

5 Long-term debt includes existing capital lease obligations, if applicable.

 

6 A multiple of eight times annual rent expense is used as an estimate of capitalizing our operating lease obligations. The methodology utilized aligns with the methodology of a nationally recognized credit rating agency.

 

7 Average invested capital represents the average of the last five fiscal quarters' ending invested capital balances.

 

8 ROIC equals NOPAT divided by average invested capital.

 

Note - Our ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

 

GAAP - generally accepted accounting principles in the U.S.

 

Source: Sleep Number Corporation

Sleep Number Corporation
Investor Contact:
Dave Schwantes, 763-551-7498
investorrelations@sleepnumber.com
or
Media Contact:
Sarah Reckard, 763-551-6076
sarah.reckard@sleepnumber.com


Search Investor Relations